(Q45085165)

English

Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension

scientific article published in February 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

type 2 diabetes

0 references

author name string

Bakris GL

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Toto RD

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

McCullough PA

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

139-144

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Microalbuminuria, blood pressure, metabolic control, and renal involvement: longitudinal studies in white non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

How high should an ACE inhibitor or angiotensin receptor blocker be dosed in patients with diabetic nephropathy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

B-type natriuretic peptide and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

21 January 2018

Diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of hypertension in adults with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001789

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.JHH.1001789

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45085165&oldid=2207091125"